• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-[2-(3-甲基喹喔啉-2-基氧基)乙基]-1,3-恶唑烷-2-酮

3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.

作者信息

Ahoya Caleb Anothane, Bouhfid Rachid, Daouda Ballo, Essassi El Mokhtar, El Ammari Lahcen

出版信息

Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 10;66(Pt 5):o1050. doi: 10.1107/S1600536810012687.

DOI:10.1107/S1600536810012687
PMID:21579110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2979098/
Abstract

Two isomers were isolated during the reaction between 3-methyl-quinoxalin-2-one and bis-(2-chloro-ethyl)amine hydro-chloride. The crystal structure of one isomer has already been reported [Caleb, Bouhfid, Essassi & El Ammari (2009). Acta Cryst. E65, o2024-o2025], while that of the second isomer is the subject of this work. The title compound, C(14)H(15)N(3)O(3), has a new structure containing oxazolidine and quinoxaline rings linked by an eth-oxy group. The main difference between the two isomers is the position of the oxazolidine group with respect to the quinoxaline system. The dihedral angle between the fused planar rings and the oxazolidin-2-one ring is 41.63 (8)° in the title mol-ecule.

摘要

在3-甲基喹喔啉-2-酮与双(2-氯乙基)胺盐酸盐的反应过程中分离出了两种异构体。其中一种异构体的晶体结构已有报道[Caleb, Bouhfid, Essassi & El Ammari (2009). Acta Cryst. E65, o2024 - o2025],而第二种异构体的晶体结构则是本研究的主题。标题化合物C(14)H(15)N(3)O(3)具有一种新结构,包含通过乙氧基相连的恶唑烷环和喹喔啉环。这两种异构体之间的主要差异在于恶唑烷基团相对于喹喔啉体系的位置。在标题分子中,稠合平面环与恶唑烷-2-酮环之间的二面角为41.63 (8)°。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aef/2979098/aff52fbb4848/e-66-o1050-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aef/2979098/d833eabe11b3/e-66-o1050-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aef/2979098/aff52fbb4848/e-66-o1050-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aef/2979098/d833eabe11b3/e-66-o1050-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5aef/2979098/aff52fbb4848/e-66-o1050-fig2.jpg

相似文献

1
3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.3-[2-(3-甲基喹喔啉-2-基氧基)乙基]-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Apr 10;66(Pt 5):o1050. doi: 10.1107/S1600536810012687.
2
3-{2-[(3-{(E)-2-[4-(Dimethyl-amino)-phen-yl]ethen-yl}quinoxalin-2-yl)-oxy]eth-yl}-1,3-oxazolidin-2-one monohydrate.3-{2-[(3-{(E)-2-[4-(二甲基氨基)-苯基]乙烯基}喹喔啉-2-基)-氧基]乙基}-1,3-恶唑烷-2-酮一水合物
Acta Crystallogr Sect E Struct Rep Online. 2012 Jan;68(Pt 1):o241. doi: 10.1107/S1600536811054481. Epub 2011 Dec 23.
3
3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.3-[2-(3-甲基-2-氧代-1,2-二氢喹喔啉-1-基)乙基]恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 29;65(Pt 8):o2024-5. doi: 10.1107/S1600536809028736.
4
Crystal structure of 5-chloro-1,3-bis-[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benz-imidazol-2(3H)-one.5-氯-1,3-双-[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-苯并咪唑-2(3H)-酮的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Sep 12;71(Pt 10):o735-6. doi: 10.1107/S2056989015016102. eCollection 2015 Oct 1.
5
2,4-Bis(4-eth-oxy-phen-yl)-7-methyl-3-aza-bicyclo-[3.3.1]nonan-9-one.2,4-双(4-乙氧基苯基)-7-甲基-3-氮杂双环-[3.3.1]壬烷-9-酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Mar 1;68(Pt 3):o779-80. doi: 10.1107/S1600536812006563. Epub 2012 Feb 17.
6
3-{2-[(3-Phenyl-quinoxalin-2-yl)-oxy]ethyl}-1,3-oxazolidin-2-one.3-{2-[(3-苯基喹喔啉-2-基)氧基]乙基}-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1235. doi: 10.1107/S1600536811014632. Epub 2011 Apr 29.
7
(S)-Ethyl 2-[4-(6-chloro-quinoxalin-2-yl-oxy)phen-oxy]propanoate.
Acta Crystallogr Sect E Struct Rep Online. 2009 Aug 8;65(Pt 9):o2082. doi: 10.1107/S1600536809030074.
8
2,4-Bis(4-eth-oxy-phen-yl)-1-methyl-3-aza-bicyclo-[3.3.1]nonan-9-one.2,4-双(4-乙氧基苯基)-1-甲基-3-氮杂双环[3.3.1]壬烷-9-酮
Acta Crystallogr Sect E Struct Rep Online. 2012 Oct 1;68(Pt 10):o2999. doi: 10.1107/S1600536812039840. Epub 2012 Sep 26.
9
3-[2-(5H-Indolo[2,3-b]quinoxalin-5-yl)eth-yl]-1,3-oxazolidin-2-one.3-[2-(5H-吲哚并[2,3-b]喹喔啉-5-基)乙基]-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Aug 28;66(Pt 9):o2461. doi: 10.1107/S1600536810033222.
10
Crystal structure of azilsartan methyl ester ethyl acetate hemisolvate.阿齐沙坦甲酯乙酸乙酯半溶剂化物的晶体结构
Acta Crystallogr E Crystallogr Commun. 2015 Jan 3;71(Pt 2):o84-5. doi: 10.1107/S2056989014028023. eCollection 2015 Feb 1.

引用本文的文献

1
3-{2-[(3-Phenyl-quinoxalin-2-yl)-oxy]ethyl}-1,3-oxazolidin-2-one.3-{2-[(3-苯基喹喔啉-2-基)氧基]乙基}-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 May 1;67(Pt 5):o1235. doi: 10.1107/S1600536811014632. Epub 2011 Apr 29.
2
3-[2-(1H-Benzimidazol-2-ylsulfan-yl)eth-yl]-1,3-oxazolidin-2-one.3-[2-(1H-苯并咪唑-2-基硫烷基)乙基]-1,3-恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2010 Nov 13;66(Pt 12):o3137. doi: 10.1107/S1600536810045897.
3
1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.

本文引用的文献

1
3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.3-[2-(3-甲基-2-氧代-1,2-二氢喹喔啉-1-基)乙基]恶唑烷-2-酮
Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 29;65(Pt 8):o2024-5. doi: 10.1107/S1600536809028736.
2
The oxazolidinone derivative locostatin induces cytokine appeasement.恶唑烷酮衍生物洛考他汀可诱导细胞因子缓和。
J Immunol. 2009 Dec 1;183(11):7489-96. doi: 10.4049/jimmunol.0901414. Epub 2009 Nov 16.
3
Structure validation in chemical crystallography.化学晶体学中的结构验证
1,3-双[2-(2-氧代-1,3-恶唑烷-3-基)乙基]-1H-苯并咪唑-2(3H)-酮
Acta Crystallogr Sect E Struct Rep Online. 2011 Jan 12;67(Pt 2):o362-3. doi: 10.1107/S1600536810052141.
Acta Crystallogr D Biol Crystallogr. 2009 Feb;65(Pt 2):148-55. doi: 10.1107/S090744490804362X. Epub 2009 Jan 20.
4
Interactions of antiviral indolo[2,3-b]quinoxaline derivatives with DNA.
J Med Chem. 2008 Dec 25;51(24):7744-50. doi: 10.1021/jm800787b.
5
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
6
Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.一些源自3-苯基喹喔啉-2(1H)-硫酮的新型喹喔啉的合成及其体外抗癌和抗菌活性评估
Arch Pharm (Weinheim). 2006 Aug;339(8):437-47. doi: 10.1002/ardp.200600012.
7
[Stereospecifity of the neuroleptic activity and chirality of (+)-3-(2-(4-(8-fluoro-2-methyl-10, 11-dihydrodibenzo(b, f)thiepin-10-yl)-1-piperazinyl)ethyl)-2-oxazolidinone (author's transl)].(+)-3-(2-(4-(8-氟-2-甲基-10,11-二氢二苯并[b,f]硫杂卓-10-基)-1-哌嗪基)乙基)-2-恶唑烷酮的抗精神病活性的立体特异性及手性(作者译)
Helv Chim Acta. 1976;59(4):1245-52. doi: 10.1002/hlca.19760590428.